Owlstone Presentations at Recent Events
Published on: 7 Jun 2023, under Events
Owlstone Medical is actively presenting some of the exciting results and progress of our many research projects ongoing at conferences and events all over the world. To catch up on our latest presentations, many of our posters and talks are available to view online. Here we summarize all the attendance of the recent and upcoming events by our team.
Catch-up on Recent Events.
AACR (14th – 19th April)
We began our mission to develop new ways to detect cancer earlier, and cancer remains one of our major research areas. The American Association for Cancer Research (AACR) Annual Meeting is one the major events where the cancer research community shares advancements in cancer, and experts including scientists, clinicians, and other healthcare professionals gather. We presented a poster here on: ‘Breath-based detection of lung cancer using exogenous volatile organic compound targeting β-glucuronidase in the tumor microenvironment’ in the Diagnostic and Prognostic Biomarkers session. The data presented demonstrated an innovative new breath test for the detection of lung cancer and provides the foundation for a phase 2 clinical trial to better understand the potential diagnostic performance of a screening test.
DDW (6th – 9th May)
Digestive health problems are increasingly becoming better understood as a major public health concern, and it has been estimated that 12% of the UK may suffer from irritable bowel syndrome (IBS). Despite how life-limiting, and how common the symptoms are, often there is very little guidance available, and few treatment options. Digestive health is one of the major areas that breath analysis can be utilized, and we recently launched our patient-centric brand OMED Health. Through this, we also partner with FGC involved in active research. We presented the results of our collaboration at Digestive Disease Week, attended by clinicians, scientists, and experts in digestive health. We had the opportunity to present two posters here, Poster 1 focused on ‘Novel Real-Time Assessment of Endogenous and Exogenous Volatile Organic Compounds (VOCs) On Breath In Healthy Subjects – Next Generation Biomarker Development for Digestive Health’, and Poster 2 focused on ‘Establishing Normal Values For Gastrointestinal Hydrogen Sulphide Production in Breath Using Selected-Ion Flow-Tube Mass Spectrometry (SIFT-MS)’.
ATS (19th – 24th May)
The American Thoracic Society (ATS) international conference was an exciting event we attended recently, where attendees involved in shaping the future of respiratory medicine had the opportunity to engage and collaborate with colleagues from all regions of the world. We presented twice at the event, Poster 1 was on the topic of ‘Investigating Induced Acute Lung Inflammation Using Breath Biopsies,’ in the Omics and the exposome: High dimensional methods in environmental lung health research session, and Poster 2 was ‘Introducing Breath Biopsy VOC Atlas: A List of Known Breath VOCS for Breath-based Biomarker Discovery,’ in the Airway injury and repair: Mechanisms and treatment Thematic Poster Session.
ASMS (4th – 8th June)
The 71st American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics took place in Houston, Texas, and we presented our work on ‘Introducing Breath Biopsy® VOC Atlas: A List of Known Breath VOCS for Breath-based Biomarker Discovery’ in the Metabolomics: New Technologies and Applications session on Wednesday the 7th of June. This work was also presented as a talk titled ‘Introducing Owlstone’s Breath Biopsy VOC Atlas: identification of breath VOCs with TD-GC-Orbitrap high resolution accurate mass spectrometry,’ the slides of which are available to view.
EACR (12th – 15th June)
The 2023 Annual Congress of the European Association for Cancer Research is dedicated to basic, preclinical, and translational cancer research across a variety of topics. We will be attending EASE this year to inspire innovation and build knowledge, connections, and collaborations. We will be presenting our work on early detection of lung cancer through two posters. Poster 1 is ‘Proof-of-mechanism study for a diagnostic probe compound generating D5-ethanol as an on-breath reporter molecule for lung cancer – Evolution phase 1‘, and Poster 2 is ‘Using exogenous volatile organic compound (EVOC) probes to target tumour-associated aldo-keto reductase activity: a potential tool to detect lung cancer‘.
EASL (21st – 24th)
The European Association for the Study of the Liver (EASL), is a medical association dedicated to excellence in liver research, and we will be attending the 2023 EASL Congress 2023. This hybrid event will bring together the global hepatology community to discuss the latest research, advancements, and hot topics in the field. We will be presenting our work in this area via our poster: ‘Dynamic Limonene Breath Testing Maximizes Classification Performance for Subjects with Cirrhosis’.
To find out more about our event attendance this year, and catch up on the full range of events we have attended, view our events page on our website.